miR-221/222-3p promotes the proliferation and metastasis of hepatocellular carcinoma (HCC), estrogen receptor (ER)-positive breast cancer cell lines (33, 34), glioma (35), pancreatic cancer (36), and colon cancer. This evidence concerns the gene ESR1 and breast carcinoma.